Last reviewed · How we verify
NCT05898698
Prospective Case Registry for Wounds
trial in Wound Healing Delayed in 300 participants. Participants enrolled and being followed up; not accepting new ones.
17 March 2025
Quick facts
| Lead sponsor | Kerecis Ltd. |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 300 |
| Start date | 17 March 2023 |
| Primary completion | 17 March 2025 |
| Estimated completion | 17 December 2025 |
| Sites | 1 location across United States |
Conditions studied
- Wound Healing Delayed — all drugs for Wound Healing Delayed →
Sponsor
Kerecis Ltd.
Who can join
Adults 18 to 90, any sex, with Wound Healing Delayed. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a post-market, observational and non-interventional registry to collect real-world data in diverse clinical settings and wound applications of acellular fish skin graft (FSG). The registry will be multi-center , target a wide patient population and a variety of wounds to document the quality of wound care, patient outcomes, safety and long-term results.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05898698
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Wound Healing Delayed
Currently open trials in the same condition.
- NCT07261501 — An Exploratory Research on the Efficacy and Safety of Antibacterial Absorbable Dressing in Chronic Non-healing Wounds · NA · recruiting
Other Kerecis Ltd. trials
Trials by the same sponsor.
- NCT06073301 — AFS Compared to AHC in Treatment of Necrotizing Fasciitis NF · Phase 4 · active not recruiting
- NCT05898711 — Kerecis Case Registry for SurgiBind : Soft Tissue Reinforcement · active not recruiting
- NCT04357990 — Viruxal Oral and Nasal Spray for Treating the Symptoms of COVID-19 · NA · completed
- NCT04257370 — Kerecis Omega3 Wound Plus SOC vs. SOC Alone in Treating Severe Diabetic Foot Ulcers and Forefoot Amputations · NA · completed
- NCT04133493 — Omega3 Wound Fish Skin Graft in the Treatment of DFUs · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05898698 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kerecis Ltd.
- Last refreshed: 30 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05898698.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing